December 14, 2025 05:14 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Caught in Thailand! Fugitive Goa nightclub owners detained after deadly fire kills 25 | After Putin’s blockbuster Delhi visit, Modi set to host German Chancellor Friedrich Merz in January | Delhi High Court slams govt, orders swift compensation as IndiGo crisis triggers fare shock and nationwide chaos | Amazon drops a massive $35 billion India bet! AI push, 1 million jobs and big plans revealed at Smbhav Summit | IndiGo’s ‘All OK’ claim falls apart! Govt slaps 10% flight cut after weeklong chaos | Centre finally aligns IndiGo flights with airline's operating ability, cuts its winter schedule by 5% | Odisha's Malkangiri in flames: Tribals rampage Bangladeshi settlers village after beheading horror! | Race against time! Indian Navy sends four more warships to Cyclone Ditwah-hit Sri Lanka | $2 billion mega deal! HD Hyundai to build shipyard in Tamil Nadu — a game changer for India | After 8 years of legal drama, Malayalam actor Dileep acquitted in 2017 rape case — what really happened?
Photo Courtesy: WHO/P. Phutpheng

With COVID-19 ‘here to stay’, new tools essential to continue fight: Tedros

| @indiablooms | Aug 30, 2023, at 09:48 pm

The World Health Organization (WHO) on Tuesday announced an expanded partnership to improve access to COVID-19 technology, knowledge and clinical data, stressing the fight against the virus must continue.

The partnership, called the COVID-19 Technology Access Pool (C-TAP), was launched in 2020, to facilitate timely, equitable and affordable access to COVID-19 health products through public health oriented, transparent and non-exclusive licensing agreements.

“COVID-19 is here to stay, and the world will continue to need tools to prevent it, test for it and treat it,” said Tedros Adhanom Ghebreyesus, WHO Director-General.

“Through C-TAP, WHO and our partners are committed to making those tools accessible to everyone, everywhere. I am grateful to the leadership shown by those license holders who have contributed technology.

As of 16 August, there have been 769,806,130 confirmed cases of COVID-19 globally, including 6,955,497 deaths, while almost 13.5 billion vaccine doses have been administered.

Important boost

The three institutions joining C-TAP include private vaccine manufacturer Medigen Vaccine Biologics Corp, the Spanish National Research Council and the University of Chile.

Medigen Vaccine Biologics Corp is offering its patent for a COVID-19 vaccine that has seen more than three million doses administered across seven countries.

Similarly, the Spanish National Research Council is sharing a license for a COVID-19 vaccine prototype, and the University of Chile, technology for quantification of neutralizing antibodies.

The addition of the three new licenses provides an important boost to the overall effort in the fight against COVID-19, WHO said. The new licenses are global, transparent and non-exclusive to all manufacturers.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.